Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$9.63
-1.9%
$10.73
$8.80
$32.71
$437.60M3.291.01 million shs757,452 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.61
+2.4%
$10.03
$8.12
$18.23
$391.48M0.54383,865 shs685,589 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.79
+0.4%
$16.73
$14.42
$23.70
$456.94M0.99201,435 shs172,233 shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$1.79
+4.7%
$2.26
$1.59
$5.77
$119M1.192.34 million shs2.02 million shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-1.93%-8.89%-9.41%-28.93%-27.05%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
+2.38%+3.11%+11.10%+27.30%-24.07%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
+0.40%+3.91%+4.96%+6.40%-23.35%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
+4.68%0.00%-24.79%-16.36%-68.65%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$9.63
-1.9%
$10.73
$8.80
$32.71
$437.60M3.291.01 million shs757,452 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.61
+2.4%
$10.03
$8.12
$18.23
$391.48M0.54383,865 shs685,589 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.79
+0.4%
$16.73
$14.42
$23.70
$456.94M0.99201,435 shs172,233 shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$1.79
+4.7%
$2.26
$1.59
$5.77
$119M1.192.34 million shs2.02 million shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-1.93%-8.89%-9.41%-28.93%-27.05%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
+2.38%+3.11%+11.10%+27.30%-24.07%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
+0.40%+3.91%+4.96%+6.40%-23.35%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
+4.68%0.00%-24.79%-16.36%-68.65%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2.67
Moderate Buy$22.00128.45% Upside
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
2.43
Hold$22.5093.80% Upside
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.82
Moderate Buy$24.4437.41% Upside
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
2.83
Moderate Buy$5.00179.33% Upside

Current Analyst Ratings Breakdown

Latest NNOX, KIDS, BBNX, and DCTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/11/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
UpgradeSell (D)Sell (D+)
5/11/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
DowngradeHoldStrong Sell
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$17.00
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingBuy$24.00
4/24/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$25.00
4/22/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Lower Price TargetOutperform$25.00 ➝ $24.00
4/22/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Lower Price TargetBuy$22.00 ➝ $20.00
4/22/2026
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
DowngradeHoldStrong Sell
4/21/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
DowngradeSell (D-)Sell (E+)
4/21/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingSell (E+)
4/20/2026
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Reiterated RatingBuy$5.00
(Data available from 5/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$100.25M4.28N/AN/A$6.09 per share1.58
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$85.23M4.70$0.05 per share216.93$3.26 per share3.56
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$243.30M1.88$0.17 per share106.56$13.19 per share1.35
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$13.02M9.57N/AN/A$2.01 per share0.89
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$73.20M-$1.51N/AN/AN/A-60.27%-23.00%-20.55%N/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.70M$0.011,161.00N/AN/A0.62%0.51%0.46%N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$39.65M-$1.68N/AN/AN/A-16.31%-7.01%-4.86%N/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$75.02M-$1.59N/AN/AN/A-790.87%-64.65%-57.27%7/20/2026 (Estimated)

Latest NNOX, KIDS, BBNX, and DCTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.0971-$0.03+$0.0671-$0.03$23.51 million$24.99 million
4/30/2026Q1 2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.4552-$0.42+$0.0352-$0.45$58.29 million$59.36 million
4/21/2026Q1 2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.53-$0.49+$0.04-$0.49N/A$27.63 million
4/20/2026Q4 2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$0.15-$0.50-$0.35-$0.50$3.99 million$3.72 million
2/26/2026Q4 2025
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.06-$0.05+$0.01-$0.05$20.35 million$20.73 million
2/26/2026Q4 2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.37-$0.26+$0.11-$0.43$61.27 million$61.61 million
2/17/2026Q4 2025
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.42-$0.30+$0.12-$0.30N/A$32.12 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
10.69
9.67
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
11.24
10.33
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.29
5.21
2.37
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/A
3.96
3.77

Institutional Ownership

CompanyInstitutional Ownership
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
21.49%

Insider Ownership

CompanyInsider Ownership
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
5.30%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
19.36%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
32.70%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
7.74%
CompanyEmployeesShares OutstandingFree FloatOptionable
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
29444.56 million42.20 millionN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
6034.52 million27.84 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
20025.69 million17.29 millionOptionable
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
19069.59 million64.20 millionOptionable

Recent News About These Companies

Nano-X falls after Q4 miss, CFO transition

New MarketBeat Followers Over Time

Media Sentiment Over Time

Beta Bionics stock logo

Beta Bionics NASDAQ:BBNX

$9.63 -0.19 (-1.93%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$9.64 +0.00 (+0.05%)
As of 07:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Delcath Systems stock logo

Delcath Systems NASDAQ:DCTH

$11.61 +0.27 (+2.38%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$11.64 +0.03 (+0.22%)
As of 07:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$17.79 +0.07 (+0.40%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$17.79 +0.00 (+0.01%)
As of 04:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Nano-X Imaging stock logo

Nano-X Imaging NASDAQ:NNOX

$1.79 +0.08 (+4.68%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$1.78 -0.02 (-0.84%)
As of 07:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.